Oxford Properties, the property arm of Canadian pension fund giant OMERS, has expanded its life sciences platform with its first European acquisition involving the AstraZeneca headquarters in Cambridge, UK.
Oxford Properties, the property arm of Canadian pension fund giant OMERS, has expanded its life sciences platform with its first European acquisition involving the AstraZeneca headquarters in Cambridge, UK.
Big pension funds, insurers and major asset managers intensified their investment activity in the week before Expo, with well over €2 bn of real estate changing hands.